|Articles|September 25, 1998

September 1998 - Special Issue
Volume 4
Issue 2 SP

Use of an Intravenous Contrast Agent (Optison) to Enhance Echocardiography: Efficacy and Cost Implications

Author(s)Leslee J. Shaw, PhD, Linda Gillam, MD, Steven Feinstein, MD

Download PDF: Use of an Intravenous Contrast Agent (Optison) to Enhance Echocardiography: Efficacy and Cost Implications

Articles in this issue

over 27 years ago

Article

Technology Assessment of Medical Devices

over 27 years ago

Article

Technology Assessment, Coverage Decisions, and Conflict: The Role of Guidelines

over 27 years ago

Article

Technology Assessment of Medical Devices at the Center for Devices and Radiological Health

over 27 years ago

Article

Role of Technology Assessment in Health Benefits Coverage for Medical Devices

over 27 years ago

Article

Transmyocardial Laser Revascularization: A Qualitative Systematic Review

over 27 years ago

Article

Device Evaluation and Coverage Policy in Workers' Compensation: Examples from Washington State

over 27 years ago

Article

The Limited State of Technology Assessment for Medical Devices: Facing the Issues

over 27 years ago

Article

Healthcare Technology Assessment: Methods, Framework, and Role in Policy Making

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

Related Content

The Health Information Technology Special Issue: Tracking Expansion Across Settings, Technologies, and Stakeholders

ByNate C. Apathy, PhD

January 27th 2026

Building Trust: Public Priorities for Health Care AI Labeling

ByMorgan L. Sielaff, BS,Jodyn Platt, PhD, MPH,Sean Tan, MPP,Kerry A. Ryan, MA,Paige Nong, PhD,Sharon L. R. Kardia, PhD

January 27th 2026

Ambient AI Tool Adoption in US Hospitals and Associated Factors

ByFreddie Yang, MA,Ilana Graetz, PhD

January 27th 2026

Motivating and Enabling Factors Supporting Targeted Improvements to Hospital-SNF Transitions

ByTaylor I. Bucy, PhD,John P. McHugh, PhD,Dori A. Cross, PhD

January 26th 2026

Specialty and Operator Status Influence Electronic Health Record Use Variation

ByPhillip D. Jenkins, MD,Gary Grunkemeier, PhD,Elizabeth Weirich, DO,An Dinh, MS,Ruchi Thanawala, MD, MS,Jeffrey A. Gold, MD,Julie Doberne, MD, PhD

January 22nd 2026

Latest CME

Online Article

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

Use of an Intravenous Contrast Agent (Optison) to Enhance Echocardiography: Efficacy and Cost Implications

Articles in this issue

Newsletter

Related Content

The Health Information Technology Special Issue: Tracking Expansion Across Settings, Technologies, and Stakeholders

Building Trust: Public Priorities for Health Care AI Labeling

Ambient AI Tool Adoption in US Hospitals and Associated Factors

Motivating and Enabling Factors Supporting Targeted Improvements to Hospital-SNF Transitions

Specialty and Operator Status Influence Electronic Health Record Use Variation

Latest CME

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

Trending on AJMC

AAP Breaks With CDC, Maintains Broader 2026 Childhood and Adolescent Vaccine Schedule

New Dermatologic Therapies Make Waves at Maui Derm 2026

Trulicity, Botox Headline Drugs Included in the Third Cycle of Medicare Price Negotiations

Experts Warn CDC Childhood Immunization Schedule Revisions Could Reduce Uptake, Erode Public Trust

CLL Breakthrough: 100% Efficacy Reported for VenR Retreatment